SCH 900460
DrugSubjects who participated in previous trials of Org 24448 (SCH 900460)
Other names: Org 24448
NCT Number: NCT00780585
This is a safety study evaluating the subjects who participated in previous Organon trials of the drug Org 24448. Patients will undergo a Screening visit, 1 or 2 Evaluation visits, and a possible Follow-Up period. During the visits, study tests, including echocardiograms, will be performed to summarize cardiac functioning.
Looking for future studies?
Notify MeAll sexes
Observational
All subjects who participated in previous Org 24448 trials and who do not meet any of the exclusion criteria are eligible.
Healthy volunteers accepted: Yes
Only the study team can determine whether someone qualifies for participation.
Inclusion criteria
Subjects must:
Exclusion criteria
Subjects must not have:
Subjects who participated in previous trials of Org 24448 (SCH 900460)
Other names: Org 24448
Time frame: During the Evaluation Period (Visit 1 or 2 and 3 if applicable).
Merck Sharp & Dohme LLC
Industry
A Multi-center Cardiac Safety Study of Subjects Who Participated in Organon Sponsored Phase 1 and Phase 2 Completed and Discontinued Trials With Org 24448
OpenTrials presents study information sourced from ClinicalTrials.gov. The official registry record should be consulted for the latest information.
View the official ClinicalTrials.gov record (opens in a new tab)This listing is for discovery and informational purposes only. It is not medical advice, does not guarantee that a study is recruiting, and does not determine eligibility. Contact the study team and a qualified healthcare professional when considering participation.
Published trials that share one or more normalized conditions with this study.
NCT05808244
Mental Disorders, Psychosis
Kowloon, Hong Kong
View Trial DetailsNCT07364825
Anxiety, Anxiety Disorders
Belmont, Massachusetts, United States
View Trial DetailsNCT04004416
Bipolar Disorder, Bipolar and Related Disorders
Ann Arbor, Michigan, United States
View Trial DetailsNCT05863572
Mental Disorders, Psychosis
Kampala, Uganda
View Trial Details